US Patent Issued to SHANDONG XINCHUANG BIOLOGICAL TECHNOLOGY on March 3 for "Antigen and antibodies prepared based on PADI4 serving as tumor marker, and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,566,177, issued on March 3, was assigned to SHANDONG XINCHUANG BIOLOGICAL TECHNOLOGY Co. LTD. (Jinan, China).

"Antigen and antibodies prepared based on PADI4 serving as tumor marker, and application thereof" was invented by Xiaotian Chang (Jinan, China), Xueyan Lv (Jinan, China), Dongxia Yang (Jinan, China), Yanqiu Xing (Jinan, China), Yuxia Gao (Jinan, China), Shili Shao (Jinan, China), Feng Liu (Jinan, China), Junchao Feng (Jinan, China), Jun Xing (Jinan, China) and Lin Li (Jinan, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "An antigen and antibodies prepared based on peptidylarginine deiminase (PADI4) serving as a tumor marker, and applicatio...